GAfPA and Alliance for Safe Biologics poster presentation, 20th International Congress of Parkinson’s Disease and Movement Disorders; MDS Congress 2016
From the Blog
Biosimilar Briefings Review Nature and Impact of Biosimilars on Access
October 1, 2019
What New Cholesterol Guidelines Mean for Patients
September 27, 2019